Alport Syndrome News

Alport Syndrome News Alport Syndrome News is the web's leading source of daily news and information for Alport patients and caregivers.

New Post: Unpacking a New Reality in the Silence https://buff.ly/33WgUVE
10/24/2019

New Post: Unpacking a New Reality in the Silence https://buff.ly/33WgUVE

Columnist Joe MacDonald remembers wrestling with the unknown in the silence surrounding a first visit to a doctor after his son's birth.

New Post: X-linked Alport Syndrome Explains Blood in Urine of Man with Rheumatoid Arthritis, Study Reports https://buff....
07/29/2019

New Post: X-linked Alport Syndrome Explains Blood in Urine of Man with Rheumatoid Arthritis, Study Reports https://buff.ly/2LMopcM

A case study details a 44-year-old man with rheumatoid arthritis, subsequently diagnosed with X-linked Alport syndrome and a COL4A5 gene mutation.

New Post: Rare Genetic Mutation Leads to Severe X-linked Alport Syndrome in 10-year-old Boy, Case Study Finds https://bu...
07/22/2019

New Post: Rare Genetic Mutation Leads to Severe X-linked Alport Syndrome in 10-year-old Boy, Case Study Finds https://buff.ly/2K9oDrl

A rare non-inherited mutation in the COL4A5 gene in a young boy led to severe X-linked Alport syndrome, according to a case report.

New Post: European Initiative Targets Diagnosis, Treatment of Rare Diseases https://buff.ly/2Y1Ea11
07/19/2019

New Post: European Initiative Targets Diagnosis, Treatment of Rare Diseases https://buff.ly/2Y1Ea11

Learn more about the EU's €101 million initiative to speed the diagnosis of rare diseases and accelerate development of therapies in 35 countries.

New Post: Review Provides Insight into Alport Patient and Research Communities https://buff.ly/2GeK1dj
07/15/2019

New Post: Review Provides Insight into Alport Patient and Research Communities https://buff.ly/2GeK1dj

A review offers news of clinical and therapeutic advances in Alport syndrome from an international gathering of patients, clinicians, and experts.

New Post: Macedonian Gaucher Activist Publicizes Plight of Rare Disease Patients https://buff.ly/32fH3il
07/10/2019

New Post: Macedonian Gaucher Activist Publicizes Plight of Rare Disease Patients https://buff.ly/32fH3il

North Macedonia's rare disease community has made major progress in funding and awareness in the past decade by reaching out to journalists.

New Post: New COL4A5 Mutation Linked to X-linked Alport in Chinese Family https://buff.ly/2S2ewrC
07/08/2019

New Post: New COL4A5 Mutation Linked to X-linked Alport in Chinese Family https://buff.ly/2S2ewrC

Chinese researchers have identified a new COL4A5 mutation that was associated with atypical renal manifestations in a boy with X-linked Alport syndrome.

New Post: World’s First Alport Stamp Is Macedonian Mom’s Latest Win for Rare Disease Patients https://buff.ly/2Jl2vJT
07/03/2019

New Post: World’s First Alport Stamp Is Macedonian Mom’s Latest Win for Rare Disease Patients https://buff.ly/2Jl2vJT

Parent and rare disease activist Gordana Loleska got her native North Macedonia to issue the world's first Alport syndrome postage stamp.

New Post: Sulfatides May Play Important Role in Early Stages of Alport Syndrome, Mouse Study Says https://buff.ly/2J6amM...
07/02/2019

New Post: Sulfatides May Play Important Role in Early Stages of Alport Syndrome, Mouse Study Says https://buff.ly/2J6amMH

Two molecules called sulfatides, found in the kidneys of a mouse model of Alport syndrome, may play an important role in early disease stages, a study says.

New Post: NORD Honors Industry, Patient Advocates at Rare Impact Awards Gala https://buff.ly/2XAYn1B
06/26/2019

New Post: NORD Honors Industry, Patient Advocates at Rare Impact Awards Gala https://buff.ly/2XAYn1B

Read about the individuals, nonprofit groups and pharmaceutical companies honored June 22 at NORD's Rare Impact Awards gala in Houston.

Address

Philadelphia, PA
19103

Alerts

Be the first to know and let us send you an email when Alport Syndrome News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share